The Pregnancy‐Induced Increase in Baseline Circulating Growth Hormone in Rats is not Induced by Ghrelin
- 16 January 2008
- journal article
- research article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 20 (3) , 309-322
Abstract
The elevation in baseline circulating growth hormone (GH) that occurs in pregnant rats is thought to arise from increased pituitary GH secretion, but the underlying mechanism remains unclear. Distribution, Fourier and algorithmic analyses confirmed that the pregnancy‐induced increase in circulating GH in 3‐week pregnant rats was due to a 13‐fold increase in baseline circulating GH (P < 0.01), without any significant alteration in the parameters of episodic secretion. Electron microscopy revealed that pregnancy resulted in a reduction in the proportion of mammosomatotrophs (P < 0.01) and an increase in type II lactotrophs (P < 0.05), without any significant change in the somatotroph population. However, the density of the secretory granules in somatotrophs from 3‐week pregnant rats was reduced (P < 0.05), and their distribution markedly polarised; the granules being grouped nearest the vasculature. Pituitary GH content was not increased, but steady‐state GH mRNA levels declined progressively during pregnancy (P < 0.05). In situ hybridisation revealed that pregnancy was accompanied by a suppression of GH‐releasing hormone mRNA expression in the arcuate nuclei (P < 0.05) and enhanced somatostatin mRNA expression in the periventricular nuclei (P < 0.05), an expression pattern normally associated with increased GH feedback. Although gastric ghrelin mRNA expression was elevated by 50% in 3‐week pregnant rats (P < 0.01), circulating ghrelin, GH‐secretagogue receptor mRNA expression and the GH response to a bolus i.v. injection of exogenous ghrelin were all largely unaffected during pregnancy. Although trace amounts of ‘pituitary’ GH could be detected in the placenta with radioimmunoassay, significant GH‐immunoreactivity could not be observed by immunohistochemistry, indicating that rat placenta itself does not produce ‘pituitary’ GH. Although not excluding the possibility that the pregnancy‐associated elevation in baseline circulating GH could arise from alternative extra‐pituitary sources (e.g. the ovary), our data indicate that this phenomenon is most likely to result from a direct alteration of somatotroph function.Keywords
This publication has 59 references indexed in Scilit:
- Hypothalamic Expression of Human Growth Hormone Induces Post-Pubertal Hypergonadotrophism in Male Transgenic Growth Retarded RatsJournal of Neuroendocrinology, 2006
- Abnormalities of the somatotrophic axis in the obese agouti mouseInternational Journal of Obesity, 2005
- Characterization and Localization of Lipocortin 1-Binding Sites on Rat Anterior Pituitary Cells by Fluorescence-Activated Cell Analysis/Sorting and Electron MicroscopyEndocrinology, 1997
- Placenta-Specific Expression of the Rat Growth Hormone-Releasing Hormone Gene Promoter in Transgenic MiceEndocrinology, 1997
- Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pigEndocrinology, 1992
- Ovine placental lactogen is a potent somatogen in the growth hormone (GH)-deficient rat: comparison of somatogenic activity with bovine GHEndocrinology, 1992
- GROWTH HORMONE SECRETION IN CHILDREN DETERMINED BY TIME SERIES ANALYSISClinical Endocrinology, 1988
- Growth Hormone Secretion during Pregnancy: Altered Effects of Growth Hormone Releasing Factor and Insulin-Like Growth Factor-I in vitroHormone Research, 1987
- Characterization of the pituitary gonadotroph cells of hypogonadal ( hpg ) male mice: comparison with normal miceJournal of Endocrinology, 1982
- Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized ratsActa Physiologica Scandinavica, 1982